Johnson & Johnson (NYSE: JNJ) announced today that 17 abstracts featuring new clinical and real-world data will be presented at the annual European College of Neuropsychopharmacology (ECNP) Congress, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback